BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3211484)

  • 21. Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: a randomized controlled trial.
    Kasetsuwan N; Reinprayoon U; Satitpitakul V
    Clin Ther; 2015 Oct; 37(10):2347-51. PubMed ID: 26409291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study.
    Lam DS; Wong AK; Fan DS; Chew S; Kwok PS; Tso MO
    Ophthalmology; 1998 May; 105(5):901-4; discussion 904-5. PubMed ID: 9593395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of mitomycin C with conjunctival autograft in pterygium surgery in Asian-Canadians.
    Wong VA; Law FC
    Ophthalmology; 1999 Aug; 106(8):1512-5. PubMed ID: 10442896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of pterygium surgery: analysis over 14 years.
    Fernandes M; Sangwan VS; Bansal AK; Gangopadhyay N; Sridhar MS; Garg P; Aasuri MK; Nutheti R; Rao GN
    Eye (Lond); 2005 Nov; 19(11):1182-90. PubMed ID: 15543190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitomycin in the treatment of hypertrophic conjunctival scars after strabismus surgery.
    Urban RC; Kaufman LM
    J Pediatr Ophthalmol Strabismus; 1994; 31(2):96-8. PubMed ID: 8014795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of beta-irradiation and mitomycin-C in primary and recurrent pterygium.
    Simşek T; Günalp I; Atilla H
    Eur J Ophthalmol; 2001; 11(2):126-32. PubMed ID: 11456012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adjuvant treatment with mitomycin eyedrops after pterygium excision: Ticino experience].
    Simona F; Anastasi-Forni C; Benedetti C; Failla FG; Rossi FM; Meyer U
    Klin Monbl Augenheilkd; 1994 May; 204(5):409-12. PubMed ID: 8051885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence rate of pterygium following surgical excision with intraoperative versus postoperative mitomycin-C.
    Rahman A; Yahya K; Ul Hasan KS
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):489-92. PubMed ID: 18798585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of intraoperative mitomycin C in surgery for pterygium.
    Panda A; Das GK; Tuli SW; Kumar A
    Am J Ophthalmol; 1998 Jan; 125(1):59-63. PubMed ID: 9437314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of recurrent pterygium surgery: limbal conjunctival autograft transplantation versus mitomycin C with conjunctival flap.
    Mutlu FM; Sobaci G; Tatar T; Yildirim E
    Ophthalmology; 1999 Apr; 106(4):817-21. PubMed ID: 10201608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of low-dose mitomycin C for prevention of recurrent pterygium.
    Frucht-Pery J; Ilsar M
    Ophthalmology; 1994 Apr; 101(4):759-62. PubMed ID: 8152772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined "symmetrical conjunctival flap transposition" and intraoperative low-dose mitomycin C in the treatment of primary pterygium.
    Uçakhan OO; Kanpolat A
    Clin Exp Ophthalmol; 2006 Apr; 34(3):219-25. PubMed ID: 16671901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pterygium excision using 193-nm excimer laser smoothing and topical mitomycin C.
    Seiler T; Schnelle B; Wollensak J
    Ger J Ophthalmol; 1992; 1(6):429-31. PubMed ID: 1490143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indications for and complications of mitomycin-C in pterygium surgery.
    Anduze AL; Burnett JM
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):667-73. PubMed ID: 8858632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical dobesilate eye drops for ophthalmic primary pterygium.
    Cuevas P; Outeiriño LA; Angulo J; Giménez-Gallego G
    BMJ Case Rep; 2012 Mar; 2012():. PubMed ID: 22605609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium.
    Cano-Parra J; Diaz-Llopis M; Maldonado MJ; Vila E; Menezo JL
    Br J Ophthalmol; 1995 May; 79(5):439-41. PubMed ID: 7612555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subconjunctival mitomycin C as adjunctive therapy before pterygium excision.
    Donnenfeld ED; Perry HD; Fromer S; Doshi S; Solomon R; Biser S
    Ophthalmology; 2003 May; 110(5):1012-6. PubMed ID: 12750105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiangiogenic therapy for pterygium recurrence].
    Leippi S; Grehn F; Geerling G
    Ophthalmologe; 2009 May; 106(5):413-9. PubMed ID: 19418056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.
    Hwang S; Choi S
    Korean J Ophthalmol; 2015 Dec; 29(6):375-81. PubMed ID: 26635453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of recurrent pterygium with intraoperative mitomycin C and conjunctival autograft with fibrin glue.
    Shehadeh-Mashor R; Srinivasan S; Boimer C; Lee K; Tomkins O; Slomovic AR
    Am J Ophthalmol; 2011 Nov; 152(5):730-2. PubMed ID: 21742307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.